2014
DOI: 10.1016/j.bbagen.2013.09.020
|View full text |Cite
|
Sign up to set email alerts
|

Tumor growth retardation and chemosensitizing action of fatty acid synthase inhibitor orlistat on T cell lymphoma: Implication of reconstituted tumor microenvironment and multidrug resistance phenotype

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
43
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(46 citation statements)
references
References 51 publications
3
43
0
Order By: Relevance
“…We also found that orlistat increased cellular ROS level and induced the expression of the cell stress proteins BIP and PERK. Previous studies in other cancer cell lines and animal studies have also shown that orlistat can induce cell stress and decrease cell proliferation, similar to our findings in endometrial cancer [20][21][22]. Our results suggest that cell cycle arrest and cellular stress also contributed to a decrease in endometrial cancer cell proliferation in response to orlistat.…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…We also found that orlistat increased cellular ROS level and induced the expression of the cell stress proteins BIP and PERK. Previous studies in other cancer cell lines and animal studies have also shown that orlistat can induce cell stress and decrease cell proliferation, similar to our findings in endometrial cancer [20][21][22]. Our results suggest that cell cycle arrest and cellular stress also contributed to a decrease in endometrial cancer cell proliferation in response to orlistat.…”
Section: Discussionsupporting
confidence: 93%
“…Previous reports have shown that orlistat can induce cell stress in lymphoma and prostate cancer [20][21][22], so we investigated whether induction of cellular stress could be a mechanism through which orlistat decreases endometrial cancer cell proliferation. Orlistat increased ROS levels in both cell lines in a dosedependent fashion ( Fig.…”
Section: Orlistat Induces Cell Stress In Endometrial Cancer Cell Linesmentioning
confidence: 99%
“…Increase production of ROS after orlistat administration has been implicated in the elevation of IFN-Îł, which manifests induction of apoptosis through inhibition of FASN expression in Dalton's lymphoma-transplanted BALB/c mice [57]. Indeed, over production of ROS in cancer cells causes impairment of cellular redox homeostasis inducing oxidative stress that consequently can make cancer cells more susceptible to oxidative stress than normal cells, which effectively balance the redox system [3], [6].…”
Section: Discussionmentioning
confidence: 99%
“…The current understanding about chemotherapy suggests that the induction of apoptosis in target cells is a key mechanism for various anticancer drugs [21,22]. Cell apoptosis is a complex process that may be achieved through activation of a cascade of intracellular factors known as caspases [23][24][25].…”
Section: Mirnas Regulate Cell Apoptosis-related Proteinsmentioning
confidence: 99%